The evidence that HK2 selective overexpression in the inflammatory synovium of RA rather than in normal tissues suggests that HK2 can serve as a metabolic target for treating RA without compromising whole-body glucose homeostasis [25]. Here, HK2 is linked to rheumatoid arthritis.